Emergent acquiring vaccine company PaxVax

By Sandi Wong | Aug 10, 2018 | 6:11 AM GMT

Biodefense company Emergent BioSolutions Inc. (NYSE:EBS) will acquire vaccine company PaxVax Inc. (Redwood City, Calif.) for $270 million